JP2022513438A5 - - Google Patents

Info

Publication number
JP2022513438A5
JP2022513438A5 JP2021531557A JP2021531557A JP2022513438A5 JP 2022513438 A5 JP2022513438 A5 JP 2022513438A5 JP 2021531557 A JP2021531557 A JP 2021531557A JP 2021531557 A JP2021531557 A JP 2021531557A JP 2022513438 A5 JP2022513438 A5 JP 2022513438A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleic acid
hiv
pharmaceutical composition
host cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531557A
Other languages
English (en)
Japanese (ja)
Other versions
JP7483234B2 (ja
JP2022513438A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063619 external-priority patent/WO2020117590A1/en
Publication of JP2022513438A publication Critical patent/JP2022513438A/ja
Publication of JP2022513438A5 publication Critical patent/JP2022513438A5/ja
Priority to JP2024068841A priority Critical patent/JP2024099671A/ja
Application granted granted Critical
Publication of JP7483234B2 publication Critical patent/JP7483234B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531557A 2018-12-04 2019-11-27 Ｈｉｖワクチン免疫原 Active JP7483234B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024068841A JP2024099671A (ja) 2018-12-04 2024-04-22 Ｈｉｖワクチン免疫原

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862775192P 2018-12-04 2018-12-04
US62/775,192 2018-12-04
PCT/US2019/063619 WO2020117590A1 (en) 2018-12-04 2019-11-27 Hiv vaccine immunogens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024068841A Division JP2024099671A (ja) 2018-12-04 2024-04-22 Ｈｉｖワクチン免疫原

Publications (3)

Publication Number Publication Date
JP2022513438A JP2022513438A (ja) 2022-02-08
JP2022513438A5 true JP2022513438A5 (https=) 2022-11-18
JP7483234B2 JP7483234B2 (ja) 2024-05-15

Family

ID=70974318

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021531557A Active JP7483234B2 (ja) 2018-12-04 2019-11-27 Ｈｉｖワクチン免疫原
JP2024068841A Pending JP2024099671A (ja) 2018-12-04 2024-04-22 Ｈｉｖワクチン免疫原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024068841A Pending JP2024099671A (ja) 2018-12-04 2024-04-22 Ｈｉｖワクチン免疫原

Country Status (10)

Country Link
US (2) US12239698B2 (https=)
EP (2) EP3891170B1 (https=)
JP (2) JP7483234B2 (https=)
KR (1) KR20210124205A (https=)
CN (2) CN119241692A (https=)
AU (2) AU2019393745B2 (https=)
CA (1) CA3120324A1 (https=)
ES (1) ES2993834T3 (https=)
PL (1) PL3891170T3 (https=)
WO (1) WO2020117590A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114732898B (zh) * 2022-04-01 2023-05-09 中国人民解放军军事科学院军事医学研究院 一种CpG佐剂与抗原定点共价结合方法
WO2024130122A2 (en) * 2022-12-15 2024-06-20 The Wistar Institute Of Anatomy And Biology Hiv immunogens and methods of using same

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4957735A (en) 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5004697A (en) 1987-08-17 1991-04-02 Univ. Of Ca Cationized antibodies for delivery through the blood-brain barrier
US5055303A (en) 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5270202A (en) 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5268164A (en) 1990-04-23 1993-12-07 Alkermes, Inc. Increasing blood-brain barrier permeability with permeabilizer peptides
US5709860A (en) 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
RO116459B1 (ro) 1991-07-25 2001-02-28 Idec Pharma Corp Compozitie imunogena
US5254342A (en) 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
DE69311538D1 (de) 1992-03-12 1997-07-17 Alkermes Inc Acth enthaltende mikrokugeln mit gesteuerter abgabe
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
EP0671926B1 (en) 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunomodulatory peptides
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5514670A (en) 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
EP1167379A3 (en) 1994-07-15 2004-09-08 University Of Iowa Research Foundation Immunomodulatory oligonucleotides
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6045802A (en) 1994-10-03 2000-04-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1003531B1 (en) 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
AU760549B2 (en) 1998-04-03 2003-05-15 University Of Iowa Research Foundation, The Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
WO2003020904A2 (en) 2001-08-31 2003-03-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods of generating human cd4+ th1 cells
US8673307B1 (en) * 2009-03-09 2014-03-18 The Rockefeller University HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120
SI3260136T1 (sl) * 2009-03-17 2021-05-31 Theraclone Sciences, Inc. Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
EP2765138B1 (en) * 2012-11-05 2018-01-10 International Aids Vaccine Initiative HIV-1 envelope glycoprotein
US10106583B2 (en) * 2014-03-07 2018-10-23 Cornell University Materials and methods for producing cleaved, HIV-1 envelope glycoprotein trimers
ES2789348T3 (es) 2015-03-20 2020-10-26 Us Health Anticuerpos neutralizantes para GP120 y sus usos
WO2016196975A1 (en) 2015-06-03 2016-12-08 The United States Of America, As Represented By The Secretary Department Of Health & Human Services Neutralizing antibodies to hiv-1 env and their use
WO2017055522A1 (en) * 2015-09-29 2017-04-06 Academisch Medisch Centrum Stabilized env proteins of hiv
WO2018161049A1 (en) * 2017-03-03 2018-09-07 Duke University Compositions and methods for inducing hiv-1 antibodies
WO2017165674A1 (en) * 2016-03-23 2017-09-28 International Aids Vaccine Initiative Immunogenic trimers
WO2019169356A1 (en) * 2018-03-02 2019-09-06 Duke University Compositions comprising hiv envelopes to induce hiv-1 antibodies

Similar Documents

Publication Publication Date Title
CN116082521B (zh) 痘病毒多抗原嵌合疫苗及其用途
EP3992210A1 (en) Novel vaccines against hpv and hpv-related diseases
JPH01279842A (ja) Ａ型及びｂ型肝炎混合アジュバントワクチン
JP2011521662A5 (https=)
JP2021529538A (ja) 重症熱性血小板減少症候群（ｓｆｔｓ）ウイルス感染疾患の予防または治療用ワクチン組成物
CN104338132A (zh) 一种病毒免疫治疗药物复合物及其用途
JP2013538195A (ja) Ｈｉｖ汚染の予防、ａｉｄｓを含むｈｉｖによって引き起こされる疾患及びｈｉｖに関連する疾患の予防及び治療のための医薬及び方法
CN116785423A (zh) 融合表达猴痘病毒保护性抗原的mRNA疫苗、递送mRNA疫苗的组合物及其制备方法和应用
US20250339511A1 (en) Nucleic acid vaccine against monkeypox virus and use thereof
JP2017520556A (ja) 抗原ペプチドを投与するための組成物、方法、及び療法
CN113769080B (zh) 多肽免疫偶联物及其应用
JP2022513438A5 (https=)
WO2020186687A1 (zh) 一种特异性结合四种血清型登革病毒的人源抗体
JPS5967226A (ja) ウイルス感染処置に使用する転移因子
US9872895B2 (en) TLR5 ligands, therapeutic methods, and compositions related thereto
WO2023184861A1 (zh) Hpv抗原表位及其鉴定方法、应用
CN115772227A (zh) 新型冠状病毒SARS-CoV-2的Delta变异株疫苗与应用
CN102218139A (zh) 一种治疗和/或预防病毒感染的药物
CN102813920A (zh) 一种疫苗佐剂
CN113185586B (zh) SARS-CoV-2编码蛋白来源的T细胞表位多肽及其应用
CN114773461B (zh) 乙型脑炎病毒抗体1d11及其应用
CA2588573C (en) Immunotherapeutic formulations to generate autoantibodies capable to avoid the binding of interleukin-2 to its receptor their use in the treatment of cancer
WO2023184862A1 (zh) Hpv抗原表位及其鉴定方法、应用
CN116059348A (zh) 基于nkg2d的细胞接合器分子在清除衰老细胞中的应用
CN106892979A (zh) 一种全人源抗h7n9病毒的中和抗体